The rotarix market research report is one of a series of new reports that provides rotarix market statistics, including rotarix industry global market size, regional shares, competitors with a rotarix market share, detailed rotarix market segments, market trends and opportunities, and any further data you may need to thrive in the rotarix industry. This rotarix market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The growth in the forecast period can be attributed to a growing population and live births, a growing number of immunity-compromised individuals, an increasing number of rotavirus-related deaths, growing immunization programs, and an increasing prevalence of rotavirus infections. Major trends in the forecast period include technological advancements, innovative formulations, multivalent vaccines, developing new technology, product innovations, and product approvals.
The rising number of deaths linked to rotavirus is anticipated to drive the growth of the rotarix market. Rotavirus-related fatalities are primarily due to severe dehydration and complications from the virus, especially in young children. The increasing number of these deaths is largely attributed to factors such as low vaccination rates, limited healthcare access, inadequate infrastructure, and insufficient treatment for dehydration. Rotarix, administered orally in two doses, helps protect infants from severe rotavirus infections by stimulating the immune system to produce antibodies against the virus. For example, in August 2024, GOV.UK reported that the cumulative number of rotavirus cases in England by week 21 of 2024 was 7% higher than the five-season average. Additionally, during weeks 18 to 21 of 2024, rotavirus activity was 28% higher than the average of the previous five seasons and 37% higher than the preceding four-week period. As a result, the growing number of rotavirus-related deaths is expected to drive the demand for rotarix.
The growing healthcare expenditure is also expected to boost the growth of the rotarix market. Healthcare expenditure encompasses all spending on medical services, healthcare products, and related services, including both public and private investments in treatment, prevention, and infrastructure. This spending is on the rise due to an aging population that demands more healthcare services and advancements in medical technologies that increase the cost of treatments and procedures. Rotarix contributes to healthcare expenditure by reducing the incidence of rotavirus infections in infants and young children, which helps lower hospitalizations, emergency care visits, and the need for expensive treatments related to severe gastroenteritis. This, in turn, reduces the financial burden on healthcare systems. For instance, in May 2023, the Office for National Statistics reported that healthcare spending in the UK reached around $354.88 billion (£283 billion) in 2022, reflecting a 0.7% increase compared to 2021. Therefore, the rising healthcare expenditure is expected to support the growth of the rotarix market.
A significant trend in the rotarix market is the development of innovative therapies aimed at preventing gastroenteritis, especially among infants and young children. These innovations focus on improving vaccine efficacy and increasing accessibility to reduce the healthcare burdens associated with rotavirus infections. Gastroenteritis, which is the inflammation of the stomach and intestines, is often caused by viral, bacterial, or parasitic infections, including rotavirus. In November 2022, GlaxoSmithKline received approval from the U.S. Food and Drug Administration for a new version of the Rotarix vaccine. This innovative formulation eliminates the need for reconstitution, making it more convenient for healthcare providers to administer. Clinical trials have shown that the new liquid version is as effective as the previous lyophilized formulation, with comparable safety results.
The countries covered in the rotarix market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Rotarix is a vaccine used to prevent rotavirus infections, which can lead to severe diarrhea and dehydration in infants and young children. It is primarily used to protect against rotavirus gastroenteritis, helping to reduce hospitalizations and severe illness linked to the virus.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main clinical indications for rotarix include the prevention of severe gastroenteritis and cross-protection. Prevention of severe gastroenteritis involves strategies aimed at reducing the risk of developing or spreading severe gastrointestinal infections caused by viruses, bacteria, or parasites. The vaccine is available in several formulations, including a liquid form and a lyophilized form, and is distributed through various channels such as hospitals, clinics, and pharmacies.
The rotavirus market consists of sales of products including syringes, needles, cold chain equipment, vials and ampoules, and sterilization equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The growth in the forecast period can be attributed to a growing population and live births, a growing number of immunity-compromised individuals, an increasing number of rotavirus-related deaths, growing immunization programs, and an increasing prevalence of rotavirus infections. Major trends in the forecast period include technological advancements, innovative formulations, multivalent vaccines, developing new technology, product innovations, and product approvals.
The rising number of deaths linked to rotavirus is anticipated to drive the growth of the rotarix market. Rotavirus-related fatalities are primarily due to severe dehydration and complications from the virus, especially in young children. The increasing number of these deaths is largely attributed to factors such as low vaccination rates, limited healthcare access, inadequate infrastructure, and insufficient treatment for dehydration. Rotarix, administered orally in two doses, helps protect infants from severe rotavirus infections by stimulating the immune system to produce antibodies against the virus. For example, in August 2024, GOV.UK reported that the cumulative number of rotavirus cases in England by week 21 of 2024 was 7% higher than the five-season average. Additionally, during weeks 18 to 21 of 2024, rotavirus activity was 28% higher than the average of the previous five seasons and 37% higher than the preceding four-week period. As a result, the growing number of rotavirus-related deaths is expected to drive the demand for rotarix.
The growing healthcare expenditure is also expected to boost the growth of the rotarix market. Healthcare expenditure encompasses all spending on medical services, healthcare products, and related services, including both public and private investments in treatment, prevention, and infrastructure. This spending is on the rise due to an aging population that demands more healthcare services and advancements in medical technologies that increase the cost of treatments and procedures. Rotarix contributes to healthcare expenditure by reducing the incidence of rotavirus infections in infants and young children, which helps lower hospitalizations, emergency care visits, and the need for expensive treatments related to severe gastroenteritis. This, in turn, reduces the financial burden on healthcare systems. For instance, in May 2023, the Office for National Statistics reported that healthcare spending in the UK reached around $354.88 billion (£283 billion) in 2022, reflecting a 0.7% increase compared to 2021. Therefore, the rising healthcare expenditure is expected to support the growth of the rotarix market.
A significant trend in the rotarix market is the development of innovative therapies aimed at preventing gastroenteritis, especially among infants and young children. These innovations focus on improving vaccine efficacy and increasing accessibility to reduce the healthcare burdens associated with rotavirus infections. Gastroenteritis, which is the inflammation of the stomach and intestines, is often caused by viral, bacterial, or parasitic infections, including rotavirus. In November 2022, GlaxoSmithKline received approval from the U.S. Food and Drug Administration for a new version of the Rotarix vaccine. This innovative formulation eliminates the need for reconstitution, making it more convenient for healthcare providers to administer. Clinical trials have shown that the new liquid version is as effective as the previous lyophilized formulation, with comparable safety results.
The key company operating in the rotarix market is GlaxoSmithKline plc
North America was the largest region in the rotarix market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in rotarix report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.The countries covered in the rotarix market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Rotarix is a vaccine used to prevent rotavirus infections, which can lead to severe diarrhea and dehydration in infants and young children. It is primarily used to protect against rotavirus gastroenteritis, helping to reduce hospitalizations and severe illness linked to the virus.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main clinical indications for rotarix include the prevention of severe gastroenteritis and cross-protection. Prevention of severe gastroenteritis involves strategies aimed at reducing the risk of developing or spreading severe gastrointestinal infections caused by viruses, bacteria, or parasites. The vaccine is available in several formulations, including a liquid form and a lyophilized form, and is distributed through various channels such as hospitals, clinics, and pharmacies.
The rotavirus market consists of sales of products including syringes, needles, cold chain equipment, vials and ampoules, and sterilization equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Rotarix Market Characteristics4. Rotarix Market Trends And Strategies5. Rotarix Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market7. Global Rotarix Pricing Analysis & Forecasts30. Global Rotarix Market Competitive Benchmarking And Dashboard31. Key Mergers And Acquisitions In The Rotarix Market32. Recent Developments In The Rotarix Market
3. Rotarix Market Biologic Drug Characteristics
6. Global Rotarix Growth Analysis And Strategic Analysis Framework
8. Rotarix Market Segmentation
9. Global Rotarix Epidemiology Of Clinical Indications
10. Rotarix Market Regional And Country Analysis
11. Asia-Pacific Rotarix Market
12. China Rotarix Market
13. India Rotarix Market
14. Japan Rotarix Market
15. Australia Rotarix Market
16. South Korea Rotarix Market
17. Western Europe Rotarix Market
18. UK Rotarix Market
19. Germany Rotarix Market
20. France Rotarix Market
21. Eastern Europe Rotarix Market
22. North America Rotarix Market
23. USA Rotarix Market
24. Canada Rotarix Market
25. South America Rotarix Market
26. Middle East Rotarix Market
27. Africa Rotarix Market
28. Rotarix Market Competitive Landscape And Company Profiles
29. Global Rotarix Market Pipeline Analysis
33. Rotarix Market High Potential Countries, Segments and Strategies
34. Appendix
Executive Summary
Rotarix Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on rotarix market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for rotarix ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rotarix market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Clinical Indication: Prevention Of Severe Gastroenteritis; Cross-Protection2) By Formulation: Liquid Formulation; Lyophilized Formulation
3) By Distribution Channel: Hospitals; Clinics; Pharmacies
Key Companies Profiled: GlaxoSmithKline plc
Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- GlaxoSmithKline plc
